SSGXXII

Trial description
Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study
Contact name
Dr Ramesh Bulusu
Trial start date
Wednesday, March 1, 2017
Trial end date
Thursday, August 2, 2018
Trial tumour type
Sarcoma
Show on Radiotherapy
No